Northwest Investment Counselors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Northwest Investment Counselors's BMY Position: Q3 2024 in Review
Northwest Investment Counselors opened a new position in Bristol-Myers Squibb (BMY) in Q3 2024: 3,024 shares worth $156K. The stake represents 0.04% of the portfolio and ranks #161 among its holdings. This is a return to the name: Northwest Investment Counselors previously reported a position in BMY as recently as Q1 2024.
Northwest Investment Counselors first reported a position in BMY in Q2 2017 and has held it in 15 quarters since. The position peaked at $247K in Q1 2023. 2,259 funds tracked by Wall St. Rank hold BMY as of Q3 2024.
- Northwest Investment Counselors held 3,024 shares of Bristol-Myers Squibb worth $156K as of Q3 2024.
- Bristol-Myers Squibb was a new Northwest Investment Counselors position in Q3 2024.
- Bristol-Myers Squibb made up 0.04% of Northwest Investment Counselors's portfolio in Q3 2024, its #161 holding.
- Northwest Investment Counselors first reported a position in Bristol-Myers Squibb in Q2 2017 and has held it in 15 quarters since.
- Northwest Investment Counselors's Bristol-Myers Squibb position peaked at $247K in Q1 2023.
- 2,259 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.
Based on Northwest Investment Counselors's 13F filing for Q3 2024, filed 21 Oct 2024.